Cell death mechanisms and regulationPhagocytosis and Immune RegulationImmune cells in cancer

K. S. Krasnov, E. I. Meshcheriakova, Y. Lomovskaya, I. S. Fadeeva, M. I. Kobyakova, R. S. Fadeev

2026.2.2Biochemistry Moscow Supplement Series A-Membrane and Cell Biology

DOI: 10.1134/s1990747825700564

tlooto Summary

This study utilized flow cytometry and spectrofluorometry to demonstrate enhanced resistance of primary CD33+ AML cells, cultured in three-dimensional multicellular aggregates, to the cytotoxic effects of anthracyclines.

Abstract

Elucidating the mechanisms of drug resistance in acute myeloid leukemia (AML) cells is a critical endeavor in biomedicine and oncohematology. In our previous research utilizing permanent cell lines, we demonstrated that AML cells in three-dimensional multicellular cultures exhibited increased drug resistance. This study utilized flow cytometry and spectrofluorometry to demonstrate enhanced resistance of primary CD33+ AML cells, cultured in three-dimensional multicellular aggregates, to the cytotoxic effects of anthracyclines. This resistance was associated with the inhibition of the pro-apoptotic signaling pathway, a partial accumulation of cells in the G0/G1 phase of the cell cycle, and an elevation in the levels of the anti-apoptotic protein Bcl-2.

Citation format

KRASNOV, K. S., et al. Resistance of CD33+ acute myeloid leukemia cells to anthracyclines in three-dimensional cultures. Biochemistry Moscow Supplement Series A-Membrane and Cell Biology, 2026, 20(1): 47–58.